Shuguang Zeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shuguang Zeng has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Gaoying Ran
Stomatological Hospital, School of Stomatology, Southern Medical University, S366 Jiangnan Boulevard, Guangzhou, Guangdong 510280, PR China
5 shared publicationsLifang Zhang
Stomatological Hospital, School of Stomatology, Southern Medical University, S366 Jiangnan Boulevard, Guangzhou, Guangdong 510280, PR China
3 shared publicationsXinping Li
Stomatological Hospital, School of Stomatology, Southern Medical University, S366 Jiangnan Boulevard, Guangzhou, Guangdong 510280, PR China
3 shared publicationsYan He
Skeletal Biology Research Center, Department of Oral Maxillofacial Surgery, Harvard School of Dental Medicine, Boston, 02114 MA, USA
3 shared publicationsYuting Peng
Department of Oral and Maxillofacial Surgery, Stomatological Hospital, Southern Medical University, Guangzhou 510280, China
3 shared publicationsHongyi Yang
Stomatological Hospital, School of Stomatology, Southern Medical University, S366 Jiangnan Boulevard, Guangzhou, Guangdong 510280, PR China
2 shared publications
Latest Publications
- 25 September 2025
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 189, 106868
β-Tricalcium phosphate nanoparticles induce macrophage polarization to M1-type through mitochondrial oxidative stress activation
- 25 September 2025
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 189, 106868
β-Tricalcium phosphate nanoparticles induce macrophage polarization to M1-type through mitochondrial oxidative stress activation
- Open Access
- 20 October 2022
- Published by Elsevier in Chinese Astronomy and Astrophysics
- Vol. 46 (3) , 264-276
An Automatic Detection for Solar Active Regions Based on Scale-Invariant Feature Transform and Clustering by Fast Search and Find of Density Peaks
- 20 October 2022
- Published by Elsevier in Chinese Astronomy and Astrophysics
- Vol. 46 (3) , 264-276
Open AccessAn Automatic Detection for Solar Active Regions Based on Scale-Invariant Feature Transform and Clustering by Fast Search and Find of Density Peaks
- Open Access
Polypeptides IGF-1C and P24 synergistically promote osteogenic differentiation of bone marrow mesenchymal stem cells in vitro through the p38 and JNK signaling pathways
Objectives Insulin-like growth factor-1 (IGF-1) and bone morphogenetic protein 2 (BMP-2) both promote osteogenesis of bone marrow mesenchymal stem cells (BMSCs). IGF-1C, the C domain peptide of IGF-1, and P24, a BMP-2-derived peptide, both have similar biological activities as their parent growth factors. This study aimed to investigate the effects and their mechanisms of polypeptides IGF-1C and P24 on the osteogenic differentiation of BMSCs. Methods The optimum concentrations of IGF-IC and P24 were explored. The effects of the two polypeptides on the proliferation and osteogenic differentiation of BMSCs were examined using the Cell Counting Kit-8(CCK-8), Alkaline phosphatase (ALP) staining, ALP activity assay, alizarin red S staining, qPCR, and western blotting. In addition, specific pathway inhibitors were utilized to explore whether p38 and JNK pathways were involved in this process. Results The optimal concentrations of action were both 50 μg/ml. IGF-1C and P24 synergistically promoted the proliferation of BMSCs, increased ALP activity and the formation of calcified nodules and upregulated the mRNA and protein levels of osterix (Osx), runt-related transcription factor 2 (Runx2), and osteocalcin (Ocn), phosphorylation level of p38 and JNK proteins also improved. Inhibition of the pathways significantly reduced the activation of p38 and JNK, blocked the expression of Runx2 while inhibiting ALP activity and the formation of calcified nodules. Conclusions These findings suggest IGF-1C and P24 synergistically promote the osteogenesis of BMSCs through activation of p38 and JNK signal pathways.
Open AccessPolypeptides IGF-1C and P24 synergistically promote osteogenic differentiation of bone marrow mesenchymal stem cells in vitro through the p38 and JNK signaling pathways
Objectives Insulin-like growth factor-1 (IGF-1) and bone morphogenetic protein 2 (BMP-2) both promote osteogenesis of bone marrow mesenchymal stem cells (BMSCs). IGF-1C, the C domain peptide of IGF-1, and P24, a BMP-2-derived peptide, both have similar biological activities as their parent growth factors. This study aimed to investigate the effects and their mechanisms of polypeptides IGF-1C and P24 on the osteogenic differentiation of BMSCs. Methods The optimum concentrations of IGF-IC and P24 were explored. The effects of the two polypeptides on the proliferation and osteogenic differentiation of BMSCs were examined using the Cell Counting Kit-8(CCK-8), Alkaline phosphatase (ALP) staining, ALP activity assay, alizarin red S staining, qPCR, and western blotting. In addition, specific pathway inhibitors were utilized to explore whether p38 and JNK pathways were involved in this process. Results The optimal concentrations of action were both 50 μg/ml. IGF-1C and P24 synergistically promoted the proliferation of BMSCs, increased ALP activity and the formation of calcified nodules and upregulated the mRNA and protein levels of osterix (Osx), runt-related transcription factor 2 (Runx2), and osteocalcin (Ocn), phosphorylation level of p38 and JNK proteins also improved. Inhibition of the pathways significantly reduced the activation of p38 and JNK, blocked the expression of Runx2 while inhibiting ALP activity and the formation of calcified nodules. Conclusions These findings suggest IGF-1C and P24 synergistically promote the osteogenesis of BMSCs through activation of p38 and JNK signal pathways.
- Open Access
- 18 May 2021
- Published by Wiley in Stem Cells International
- Vol. 2021, 1-17
Biocompatibility and Angiogenic Effect of Chitosan/Graphene Oxide Hydrogel Scaffolds on EPCs
Angiogenesis in the field of tissue engineering has attracted significant attention. Graphene oxide has become a promising nanomaterial in tissue engineering for its unique biochemical properties. Therefore, herein, a series of chitosan (CS)/graphene oxide (GO) hydrogel scaffolds were synthesized by crosslinking CS and GO at different concentrations (0.1, 0.5, and 1.0 wt.%) using genipin. Compared with the CS hydrogel scaffolds, the CS/GO hydrogel scaffolds have a better network structure and mechanical strength. Then, we used endothelial progenitor cells (EPCs) extracted from human umbilical cord blood and cocultured these EPCs with the as-prepared scaffolds. The scaffolds with 0.1 and 0.5 wt.%GO showed no considerable cytotoxicity, could promote the proliferation of EPCs and tube formation, and upregulated the expressions of CD34, VEGF, MMP9, and SDF-1 in EPCs compared to the case of the scaffold with 1.0 wt.%GO. This study shows that the addition of graphene oxide improves the structure of chitosan hydrogel and enhances the proliferation activity and angiogenic capacity of EPCs.
- 18 May 2021
- Published by Wiley in Stem Cells International
- Vol. 2021, 1-17
Open AccessBiocompatibility and Angiogenic Effect of Chitosan/Graphene Oxide Hydrogel Scaffolds on EPCs
Angiogenesis in the field of tissue engineering has attracted significant attention. Graphene oxide has become a promising nanomaterial in tissue engineering for its unique biochemical properties. Therefore, herein, a series of chitosan (CS)/graphene oxide (GO) hydrogel scaffolds were synthesized by crosslinking CS and GO at different concentrations (0.1, 0.5, and 1.0 wt.%) using genipin. Compared with the CS hydrogel scaffolds, the CS/GO hydrogel scaffolds have a better network structure and mechanical strength. Then, we used endothelial progenitor cells (EPCs) extracted from human umbilical cord blood and cocultured these EPCs with the as-prepared scaffolds. The scaffolds with 0.1 and 0.5 wt.%GO showed no considerable cytotoxicity, could promote the proliferation of EPCs and tube formation, and upregulated the expressions of CD34, VEGF, MMP9, and SDF-1 in EPCs compared to the case of the scaffold with 1.0 wt.%GO. This study shows that the addition of graphene oxide improves the structure of chitosan hydrogel and enhances the proliferation activity and angiogenic capacity of EPCs.
- 11 October 2020
- Published by Wiley in Journal of Periodontology
- Vol. 92 (7) , 1049-1059
The role of PHF8 and TLR4 in osteogenic differentiation of periodontal ligament cells in inflammatory environment
Background: Histone methylation is considered to play an important role in the occurrence and development of periodontitis. Plant homeodomain finger protein 8 (PHF8), a histone demethylase, has been shown to regulate inflammation and osteogenic differentiation of bone marrow stromal cells (BMSCs). This study aimed to detect the functions of PHF8 and TLR4 in osteogenic differentiation in an inflammatory environment induced by Porphyromonas gingivalis lipopolysaccharide (Pg‐LPS)Methods: A periodontitis mouse model was established, and the mice were treated with TAK‐242. Immunohistochemical staining was used to detect the expression of PHF8 in periodontal tissue. Periodontal ligament cells (PDLCs) were treated with mineralization induction medium supplemented with Pg‐LPS and/or TAK‐242, and a Cell Counting Kit‐8 (CCK‐8) assay was used to detect the proliferation of PDLCs. Real‐time PCR and western blotting were used to detect the mRNA and protein expression levels, respectively, of PHF8, toll‐like receptor 4 (TLR4) and the other osteogenic markers alkaline phosphatase (ALP), osteocalcin (OCN), Special AT‐rich sequence‐binding protein 2 (Satb2) and Runt‐related transcription factor 2 (Runx2)Results: Periodontitis reduced PHF8 expression in periodontal tissue, and TAK‐242 partially reversed this downregulation. An in vitro experiment revealed that the mRNA and protein expression levels of PHF8 were significantly upregulated during the osteogenic differentiation of PDLCs. Alizarin red staining showed that the mineralized nodules of PDLCs in osteogenic induction group were more than those in control group. Real‐time PCR and western blot results indicated that Pg‐LPS inhibited PHF8 expression and upregulated TLR4 expression in PDLCs. TAK‐242 inhibited TLR4 and partially reversed the inhibition of PHF8 expression and osteogenic differentiation induced by Pg‐LPS in PDLCsConclusion: PHF8 and TLR4 play important roles in periodontitis. Pg‐LPS inhibits the expression of PHF8 via upregulation of TLR4 and might further inhibit the osteogenic differentiation of PDLCs. However, the specific mechanisms involved remain to be explored.
- 11 October 2020
- Published by Wiley in Journal of Periodontology
- Vol. 92 (7) , 1049-1059
The role of PHF8 and TLR4 in osteogenic differentiation of periodontal ligament cells in inflammatory environment
Background: Histone methylation is considered to play an important role in the occurrence and development of periodontitis. Plant homeodomain finger protein 8 (PHF8), a histone demethylase, has been shown to regulate inflammation and osteogenic differentiation of bone marrow stromal cells (BMSCs). This study aimed to detect the functions of PHF8 and TLR4 in osteogenic differentiation in an inflammatory environment induced by Porphyromonas gingivalis lipopolysaccharide (Pg‐LPS)Methods: A periodontitis mouse model was established, and the mice were treated with TAK‐242. Immunohistochemical staining was used to detect the expression of PHF8 in periodontal tissue. Periodontal ligament cells (PDLCs) were treated with mineralization induction medium supplemented with Pg‐LPS and/or TAK‐242, and a Cell Counting Kit‐8 (CCK‐8) assay was used to detect the proliferation of PDLCs. Real‐time PCR and western blotting were used to detect the mRNA and protein expression levels, respectively, of PHF8, toll‐like receptor 4 (TLR4) and the other osteogenic markers alkaline phosphatase (ALP), osteocalcin (OCN), Special AT‐rich sequence‐binding protein 2 (Satb2) and Runt‐related transcription factor 2 (Runx2)Results: Periodontitis reduced PHF8 expression in periodontal tissue, and TAK‐242 partially reversed this downregulation. An in vitro experiment revealed that the mRNA and protein expression levels of PHF8 were significantly upregulated during the osteogenic differentiation of PDLCs. Alizarin red staining showed that the mineralized nodules of PDLCs in osteogenic induction group were more than those in control group. Real‐time PCR and western blot results indicated that Pg‐LPS inhibited PHF8 expression and upregulated TLR4 expression in PDLCs. TAK‐242 inhibited TLR4 and partially reversed the inhibition of PHF8 expression and osteogenic differentiation induced by Pg‐LPS in PDLCsConclusion: PHF8 and TLR4 play important roles in periodontitis. Pg‐LPS inhibits the expression of PHF8 via upregulation of TLR4 and might further inhibit the osteogenic differentiation of PDLCs. However, the specific mechanisms involved remain to be explored.